Home > Signaling Pathways>Neuronal Signaling>Calcium Channel>Ranolazine 2HCl (RS-43285; CVT-303)
Ranolazine 2HCl (RS-43285; CVT-303)

This product is for research use only, not for human use. We do not sell to patients.

Ranolazine 2HCl (RS-43285; CVT-303)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
2g$240Check With Us
5g$500Check With Us
10g$750Check With Us

Cat #: V0368 CAS #: 95635-56-6 Purity ≥ 98%

Description: Ranolazine 2HCl (known also as Ranolazine diHydrochloride), the diHCl salt of ranolzaine (RS43285; CVT303), is a an anti-angina drug which acts as a potent calcium uptake inhibitor via the sodium/calcium channel, it is used to treat chronic angina.

References: Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. 2001 Apr 20;418(1-2):105-10.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)500.46
Molecular FormulaC24H33N3O4.2HCl
CAS No.95635-56-6
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 100 mg/mL (199.8 mM)r
Water: 100 mg/mL (199.8 mM)r
Ethanol: <1 mg/mL
Solubility In VivoChemical Name: N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride InChi Key: RJNSNFZXAZXOFX-UHFFFAOYSA-N InChi Code: InChI=1S/C24H33N3O4.2ClH/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3;;/h4-10,20,28H,11-17H2,1-3H3,(H,25,29);2*1H SMILES Code: O=C(NC1=C(C)C=CC=C1C)CN2CCN(CC(O)COC3=CC=CC=C3OC)CC2.[H]Cl.[H]Cl
SynonymsRS-43285; RS43285; RS 43285; CVT 303; CVT303; CVT-303; Ranolazine; Ranexa; Latixa; Ranolazine Dihydrochloride; Ranolazine Hydrochloride; Ranolazine HCl; .
ProtocolIn VivoRanolazine (Bolus injection 10 mg/kg and infusion 9.6 mg/kg/h; bolus injection; for 145 minutes; male Wistar rats) treatment significantly reduces infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion
Animal modelMale Wistar rats (240-350 g)
DosagesBolus injection 10 mg/kg and infusion (9.6 mg/kg/h)
Administration Bolus injection; for 145 minutes
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.9982 mL9.9908 mL19.9816 mL39.9632 mL
5mM0.3996 mL1.9982 mL3.9963 mL7.9926 mL
10mM0.1998 mL0.9991 mL1.9982 mL3.9963 mL
20mM0.0999 mL0.4995 mL0.9991 mL1.9982 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.